Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Evan Bradner"'
Autor:
Julia McCain, William T. Sparks, Dmytro Havrylyuk, Colin G. Cameron, John Roque, Susan Monro, Sherri A. McFarland, Katsuya L. Colón, Tariq Sainuddin, Edith C. Glazer, Patrick C. Barrett, Evan Bradner, David K. Heidary
Publikováno v:
Photochem Photobiol
A series of strained Ru(II) complexes were studied for potential anticancer activity in hypoxic tissues. The complexes were constructed with methylated ligands that were photolabile and an imidizo[4,5-f][1,10]phenanthroline ligand that contained an a
Autor:
S.D. Kim, Evan Bradner, Colin G. Cameron, Marta E. Alberto, Patrick C. Barrett, Gagan Deep, John Roque, Ge Shi, Nino Russo, Sherri A. McFarland, David von Dohlen, Houston D. Cole, Liubov M. Lifshits
Publikováno v:
Inorg Chem
Hypoxia presents a challenge to anticancer therapy, reducing the efficacy of many available treatments. Photodynamic therapy (PDT) is particularly susceptible to hypoxia given that its mechanism relies on oxygen. Herein, we introduce two new osmium-b
Autor:
Lindsey Carlsen, Taylor Mandeville, Evan Bradner, Tariq Sainuddin, Sherri A. McFarland, Patrick C. Barrett, Gal Shafirstein, Sarah Chamberlain, David A. Bellnier
Publikováno v:
17th International Photodynamic Association World Congress.
Ruthenium and osmium-based photosensitizers (PS) are compounds of interest for use in photodynamic therapy (PDT). These PS’s can be activated by light wavelengths in the range of 400-675 nm, which can be selected based on the tumor environment, tre
Autor:
Susan Monro, Katsuya L. Colón, Tariq Sainuddin, Marc Hetu, Goutam Ghosh, Sherri A. McFarland, Anderson Fuller, Huimin Yin, Evan Bradner, Julia McCain, Colin G. Cameron
Publikováno v:
Inorganic chemistry. 57(13)
The photophysical and photobiological properties of a new class of cyclometalated ruthenium(II) compounds incorporating π-extended benzo[h]imidazo[4,5-f]quinoline (IBQ) cyclometalating ligands (C^N) bearing thienyl rings (n=1–4, compounds 1–4) w